期刊文献+

肠胃清口服液抑制结肠癌细胞LS-174T侵袭转移的体外研究 被引量:14

Inhibitive effects of Changweiqing oral liquid on invasion and metastasis of colon cancer cell line LS-174T
原文传递
导出
摘要 [目的]研究肠胃清口服液在体外抑制结肠癌细胞侵袭转移的作用。[方法]SD大鼠肠胃清连续灌胃给药3 d后断头取血,分离血清,MTT法检测结肠癌细胞LS-174T与人工基底膜的黏附能力;划痕试验测定细胞的运动能力;浸润杯试验法研究细胞的浸润能力。[结果]肠胃清药物血清可以有效地抑制肿瘤细胞黏附能力[半数有效浓度(EC50)为90μl//ml];抑制LS-174T癌细胞移动(EC50为100μl/ml);肠胃清药物血清处理过的结肠癌细胞浸润穿过Matrigel膜的细胞数要比对照的细胞数明显减少,100μl/ml肠胃清药物血清对细胞浸润的抑制率达到56%。[结论]肠胃清口服液可以通过抑制结肠癌细胞的黏附、运动、浸润能力,抑制肿瘤的侵袭转移。 [Objective] To explore the effects of Changweiqing oral liquid (COL) on the invasion and metastasis of colon cancer cell in vitro. [Methods] Melanoma cells B16BL6 were injected into C57BL/6 mice by caudal vein, then the mice were randomly divided into five groups: the control group, Dacarbazine group, low dose of COL group(12. 5 g/kg), moderate dose group(25 g/kg) and high dose group(50 g/kg). The mice's weight, behaviour and metastasis points were obversed . The serum was obtained from SD rats which had been fed with COL twice a day for three days. The adhesiveness, migration and invasion were measured by MTT assay, wound healing assay and transwell assay respectively. [Results] COL had no effect on the weight and bahaviour of mice. COL significantly inhibited metastasis in lung in the moderate and high dose groups. The serum containing of COL could inhibit adhesiveness and migration of colon cancer cell line LS-174T , the EC50 of which were 90 μl/ml, 100 μl/ml respectively. Compared with that of control group, the number of cells that infiltrated and went straight through matrigel membrane significantly decreased after the cells had been dealt with the serum. The inhibition rate of invation was 56 % when the serum concentration was 100μl/ml. [Conclusion]COL can restrain invasion and metastasis of colon cancer cells by inhibiting it's ability of adhesiveness, migration and invasion.
出处 《中国中西医结合消化杂志》 CAS 2005年第6期357-359,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
关键词 结肠肿瘤 肠胃清口服液 肿瘤转移 colon cancer Changweiqing oral liquid metastasis
  • 相关文献

参考文献7

  • 1ZHENG S, CAI S R. Colorectal cancer epidemiology and prevention study in china [J ]. Chin Germ J Clin Oncol, 2003,2: 72.
  • 2郁宝铭.结直肠癌辅助化疗的进展与评估[J].腹部外科,2001,14(1):10-12. 被引量:5
  • 3许建华,李朝衡,朱美华,孙珏,范忠泽.肠胃清口服液抗肿瘤作用研究[J].中药药理与临床,2004,20(4):42-43. 被引量:15
  • 4孙珏 范忠泽 朱美华.肠胃清口服液对体外培养的人结肠癌细胞作用研究[J].中医杂志,2003,44:102-102.
  • 5刘建文.抗肿瘤转移作用的实验方法[A].见:刘建文主编.药理实验方法学--新技术与新方法[M].北京:化学工业出版社,2003.30-59.
  • 6JIAN D L, SHENG H C,CHIH L L, et al. Inhibition of melanoma growth and metastasis by combination with(- )Epigallocatechin3-Gallate and dacarbazine in mice[J]. J Cellular Biochem,2001,83:631.
  • 7郑宏强,刘德育.蛇葡萄素抗黑色素瘤侵袭和转移的作用[J].癌症,2003,22(4):363-367. 被引量:31

二级参考文献17

  • 1刘德育,罗曼.血清药理学方法研究蛇葡萄素抗B16黑色素瘤的作用[J].中药材,2001,24(5):348-350. 被引量:17
  • 2王玫馨,刘文粢,黄爱东,罗丽卿,周爱群.无莉根黄酮类成分的分离和鉴定[J].中药材,1989,12(7):28-29. 被引量:13
  • 3[1]Buyse M, Zeleniuch-Jacquotto A, Chalmers TC. Adjuvant therapy of colorectal cancer: Why we still don't know. JAMA, 1988, 259:3571~3578.
  • 4[2]Higgens GA, Amadeo JH, Mc Elhinney J, et al. Efficacy of prolonged intermittent therapy withcombined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. Cancer, 1984, 53:1~8.
  • 5[3]Wolmark N, Fisher B, Rockette H, et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NASBP protocol C-01. J Natl Cancer Inst, 1988, 80:30~36.
  • 6[4]Moertel CG, Fleming TR, Mac Donald JS, et al. Levamisole and fluorouracil for adjuvamtherapy of resected colon carcinoma. N Engl J Med, 1990, 322:352~358.
  • 7[5]Connell MJ, Mailliard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low doseleucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol, 1997, 15:246~250.
  • 8[6]Zaniboni A, labianca R, Marsoni S, et al. A randomized triai of adjuvant 5-fluoruracil andnic acid administered to patients with colon carcinomaf: Long term results and evaluation of the indicators of health-related quality of life. Cancer, 1998, 82:2135~2144.
  • 9[7]Wolmark N, Rockette H, Mamounas EP, et al. The relative efficacy of 5-Fu and leucovorin(Fu-LV), 5-Fu and levamisole(Fu-Lev) and 5-Fu and leucovorin and levamisole(Fu-LV-Lev) in patients with Duke's B and C carcinoma of the colon f first report of NSABP C-04 [abstract 460].Proceedings of the American Society of Clinical Oncology, 1996, 15:205.
  • 10[8]Haller DG, Catalano PJ, Macdonald JS, et al. Fluorouracil(Fu) leu-covorin(LV) and levamisole(Lev) adjuvont therapy for colon cancer: Five-year final report of INT-089 [abstract 982]. Proceedings of the American Society of Clinical Oncology, 1998, 17:256.

共引文献48

同被引文献185

引证文献14

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部